Cited by

• The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.

  Kramer MD, Wallich R, Simon MM. Kramer MD, et al. Infection. 1996 Mar-Apr;24(2):190-4. doi: 10.1007/BF01713338. Infection. 1996. PMID: 8740121 Review.
• Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

  Wallich R, Brenner C, Kramer MD, Simon MM. Wallich R, et al. Infect Immun. 1995 Sep;63(9):3327-35. doi: 10.1128/iai.63.9.3327-3335.1995. Infect Immun. 1995. PMID: 7642261 Free PMC article.
• Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.

  Dykhuizen DE, Polin DS, Dunn JJ, Wilske B, Preac-Mursic V, Dattwyler RJ, Luft BJ. Dykhuizen DE, et al. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10163-7. doi: 10.1073/pnas.90.21.10163. Proc Natl Acad Sci U S A. 1993. PMID: 8234271 Free PMC article.
• Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

  Krause A, Burmester GR, Rensing A, Schoerner C, Schaible UE, Simon MM, Herzer P, Kramer MD, Wallich R. Krause A, et al. J Clin Invest. 1992 Sep;90(3):1077-84. doi: 10.1172/JCI115923. J Clin Invest. 1992. PMID: 1522216 Free PMC article.
• Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi.

  Wallich R, Simon MM, Hofmann H, Moter SE, Schaible UE, Kramer MD. Wallich R, et al. Infect Immun. 1993 Oct;61(10):4158-66. doi: 10.1128/iai.61.10.4158-4166.1993. Infect Immun. 1993. PMID: 8104894 Free PMC article.